Heart Disease Clinical Trials in Atlanta

Showing 161-180 of 252 trials

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

NCT03170219

To determine if a strategy of early discharge using a novel subcutaneous delivery system for parenteral furosemide can improve clinical outcomes within 30 days of randomization (days alive and outside the hospital) compared to usual care.

Acute Heart FailureDecompensated Heart Failure

Adrian Hernandez11 participantsStarted Apr 2018

Atlanta, Georgia, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +13 more locations

COMPLETEDNA< 1 mile

Sapphire II PRO US Clinical Study

NCT03052530

A prospective, open label, multi-center, single arm, observational study designed to evaluate the acute safety and device procedural success of the Sapphire II PRO 1.0 and 1.25 mm PTCA dilatation catheters in subjects with stenotic coronary arteries or bypass grafts during percutaneous coronary intervention. Sixty (60) subjects will be treated at up to 5 U.S. sites with the Sapphire II PRO diameters 1.0 and 1.25 mm PTCA dilatation catheters to pre-dilate coronary arteries or bypass grafts during their index procedure. All subjects will be screened according to the protocol inclusion and exclusion criteria and will be followed through hospital discharge.

Coronary Artery DiseaseCoronary DiseaseMyocardial Ischemia+3 more

OrbusNeich61 participantsStarted May 2017

Miami, Florida, United States • Atlanta, Georgia, United States • Salisbury, Maryland, United States +1 more locations

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

Sapphire II PRO US Clinical Study

Heart Disease Trials in Other Cities

Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Detection of Subclinical Atherosclerosis in Asymptomatic Individuals

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Naltrexone/Bupropion Cardiovascular Outcomes Study

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

Get Going: Accelerometer-Based Intervention to Promote Physical Activity in Frail Older Adults

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension

An Assessment of the Glider Balloon in Complex Lesions

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in Atlanta